Eli Lilly and Company “Very Much Opposed” to Merger: CEO

March 21, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BEIJING (Reuters) - Drugmaker Eli Lilly (NYSE:LLY - News), which faces plunging sales due to competition and lapsing patents, will not merge with another peer to ride out any rough times ahead, chief executive John Lechleitr said on Saturday.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions Asia

Eli Lilly and Company